Immunoassay Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new research report on "Immunoassay Market-Global Forecast 2023". The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2018-2023 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-109788

The immunoassay market is estimated to reach US $ 27.15 billion by 2023 from US $ 20.19 billion in 2018 and is expected to grow at a CAGR of 6.1%.

Increasing rates of chronic and infectious diseases, technological advances in immunoassay equipment and the introduction of new automation systems, and the growth of the biotechnology and biopharmacy industry are several factors contributing to the growth of the market. In addition, factors such as the increasing adoption of immunoassay-based point-of-care and rapid testing and the important role of immunoassays in drug and alcohol testing are also expected to drive growth in this market.

Market segment

The immunoassay market is by product / service (reagent / kit, analyzer, software), technology (ELISA, rapid testing), platform (radioimmunoassay), sample, application (infectious disease, oncology, heart disease). It is divided into academic), end user (hospital) and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Report sample URL
https://www.sdki.jp/sample-request-109788

The hospital segment is expected to dominate the market during the forecast period.

Based on end users, the immunoassay market is divided into hospitals, clinical laboratories, blood banks, research and academic laboratories, pharmaceutical and biotechnology companies, contract research organizations (CROs), and other end users. The hospital segment is expected to grow at a significant CAGR during the forecast period. Immunoassays are widely used in hospitals and laboratories attached to hospitals for the diagnosis of infectious diseases. This is expected to drive growth in this segment.

Area overview

In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa and more. The Asia Pacific immunoassay market is estimated to register the largest CAGR during the forecast period. Growth in the region can be attributed to the demand for better medical services, increased incidence of chronic and infectious diseases, and the rapid development of medical infrastructure in developing countries such as India, China and South Korea. In addition, increased investment in healthcare research in the region and increased per capita income for the region's middle-class population are also expected to contribute to the growth of the region's market.

For more detailed analysis, each region is further divided into countries:
Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific)
North America (US and Canada)
Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa)
Latin America (Brazil, Mexico, Argentina, and other Latin America)
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe).

Detailed contents of the survey report

https://www.sdki.jp/reports/immunoassay-market/109788

Key Players:

In the market are DiaSorin (Italy), Siemens (Germany), bioMérieux (France), Abbott Laboratories (USA), Roche (Switzerland), Sysmex Corporation (Japan), Danaher Corporation. (USA), Ortho Clinical Diagnostics (USA), Thermo Fisher Scientific (USA), QIAGEN (Netherlands), Becton, Dickinson and Company (USA), Bio-Rad Laboratories (USA), Merck (Germany), Agilent Technologies (USA) , Quidel Corporation (USA), Bio-Techne Corporation (USA), PerkinElmer (USA), Mindray (China) and more. The study includes in-depth competitive analysis, company profiles, recent developments, and key market strategies for these major companies in the immunoassay market.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.